Metabolic syndrome prevalence
Metric MH-07 · Series MH: America's Metabolic Health
Metabolic syndrome prevalence was 38.5% in 2023, according to CDC, NHANES.
This figure is reported as Metric MH-07 in The State of Metabolic Health in America, 2026 Baseline Edition: Annual Policy Report (James M. Knox, DOI: 10.5281/zenodo.22772957).
Definition
This metric measures metabolic syndrome prevalence among u.s. adults. The unit of measurement is percent of adults. The geographic scope is United States.
Requires several risk factors to be present together by clinical definition.
Current Value
| Value | Data Year | Population | Geography |
|---|---|---|---|
| 38.5% | 2023 | U.S. adults | United States |
Source
CDC, NHANES.
Methodological Notes
This figure is drawn from CDC, NHANES. Where a second source reports a different figure for the same condition, both values and the reason for the discrepancy are documented in the report rather than reconciled.
See Methodology and Sources for the full source selection criteria and conflict resolution approach.
Related Metrics
Cite This Metric
Last reviewed: October 2026